GM-CSF is a well-known haemopoietic growth factor that is used in the clinic to correct neutropaenia, usually as a result of chemotherapy. GM-CSF also has many pro-inflammatory functions and recent data implicates GM-CSF as a key factor in Th17 driven autoimmune inflammatory conditions. In this review we summarize the findings that have led to the development of GM-CSF antagonists for the treatment of autoimmune diseases like rheumatoid arthritis (RA) and discuss some results of recent clinical trials of these agents.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.molimm.2013.05.002 | DOI Listing |
Publication Analysis
Top Keywords
gm-csf
5
gm-csf therapeutic
4
therapeutic target
4
target inflammatory
4
inflammatory diseases
4
diseases gm-csf
4
gm-csf well-known
4
well-known haemopoietic
4
haemopoietic growth
4
growth factor
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!